Tag Archives: fox-news/health/nutrition-and-fitness/obesity

Hairstylists and medical expert confirm temporary hair loss affecting Ozempic users

NEWYou can now listen to Fox News articles! Side effects from GLP-1s can vary — but one lesser-known reported outcome of the popular weight-loss medications is hair loss or thinning. Some hairstylists have confirmed an uptick in clients who complain about losing hair while on weight-loss journeys. This includes Ashley DiMatteo, owner of Ashley Lauren Beauty Lounge in Westchester, New …

Read More »

Low-calorie diets linked to surprising mental health effect, new research shows

NEWYou can now listen to Fox News articles! Embarking on a low-calorie diet could potentially lead to negative mental health, researchers in Toronto, Canada, have revealed. A new study, published in BMJ Nutrition, Prevention and Health, investigated how the adoption of restrictive diets could instigate depressive symptoms. Using the National Health and Nutrition Examination Survey, researchers analyzed nearly 29,000 adults …

Read More »

Who should be taking weight-loss drugs? Doctors share best candidates

NEWYou can now listen to Fox News articles! Weight-loss drugs continue to grow in popularity, with market researchers predicting that global demand for the medications could reach $150 billion by 2035. GLP-1 agonists — including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound — are intended to treat type 2 diabetes and obesity. Recent studies, however, have …

Read More »

Is Ozempic ruining your teeth? What to know about impact on dental health

Khloe Quill is a lifestyle production assistant with Fox News Digital. She and the lifestyle team cover a range of story topics including food and drink, travel, and health. 

Read More »

Turkey weighing citizens in public to fight obesity, critics slam the move as fat shaming

Turkey is tipping the scales in its war on obesity. The country has launched a nationwide campaign to measure citizens’ weight in public spaces to combat its rising obesity rates — a move critics argue amounts to public fat shaming and government overreach.  The initiative, called “Learn Your Ideal Weight, Live Healthy” campaign, will see around 10 million people assessed …

Read More »

Scientists may have discovered why the pounds come back after losing weight

Many factors lead to the frustrating cycle of weight gain and weight loss — but the driving force may be fat cells keeping a memory of obesity. That’s according to a recent study that was first published in the journal Nature last fall. Researchers say that fat cells influence abnormal metabolic pathways in the body long after pounds are shed, which …

Read More »

Study directly compares Zepbound and Wegovy for weight-loss results

Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New England Journal of Medicine. Researchers compared the safety and efficacy of tirzepatide (brand name Zepbound) and semaglutide (brand name Wegovy) in a 72-week clinical trial. WEIGHT-LOSS MEDICATIONS …

Read More »

Doctors warn of ‘trifecta’ of chronic illnesses plaguing Americans after MAHA report

Chronic diseases have long been plaguing Americans, which HHS Secretary Robert F. Kennedy Jr. has called an “epidemic.” The MAHA Commission, which Kennedy chairs, released a report on Thursday assessing chronic diseases, particularly pertaining to children. An estimated 133 million Americans suffer from at least one chronic illness, according to the American Hospital Association. EVERYTHING TO KNOW ABOUT MAHA “The …

Read More »

Weight-loss medications may also benefit common medical problem, study finds

Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists, which have gained popularity for treating type 2 diabetes and obesity, have been shown to have the surprising secondary benefit of reducing alcohol intake. A team of international researchers from Ireland and Saudi Arabia followed 262 adult patients with obesity who started taking two GLP-1 medications: liraglutide or semaglutide. Among the regular …

Read More »

Weight loss, diabetes drugs can cause mood changes: What to know about behavioral side effects

GLP-1 receptor agonists (GLP-1 RAs), medications that help control type 2 diabetes and obesity, can have a profound impact on physical wellness – but what about mental health? Some examples of these medications include semaglutides, such as Ozempic and Wegovy, and liraglutide, like Victoza and Saxenda. Various studies have pointed toward GLP-1 RAs causing mental health complications, such as anxiety …

Read More »